Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: QYResearch | PRODUCT CODE: 1343822

Cover Image

PUBLISHER: QYResearch | PRODUCT CODE: 1343822

Global Pharmaceutical Validation Services Market Insights, Forecast to 2029

PUBLISHED:
PAGES: 105 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF (Single User License)
USD 4900
PDF (Multi User License)
USD 7350
PDF (Enterprise User License)
USD 9800

Add to Cart

This research report focuses on the Pharmaceutical Validation Services Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Pharmaceutical Validation Services Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
    • 1.2.2 Pharmaceutical Cleaning Validation Services
    • 1.2.3 Pharmaceutical Equipment Validation Services
    • 1.2.4 Others
  • 1.3 Market by Application
    • 1.3.1 Global Pharmaceutical Validation Services Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
    • 1.3.2 Pharmaceutical Companies
    • 1.3.3 Biotechnological Companies
    • 1.3.4 Academic and Research Institutes
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Global Growth Trends

  • 2.1 Global Pharmaceutical Validation Services Market Perspective (2018-2029)
  • 2.2 Global Pharmaceutical Validation Services Growth Trends by Region
    • 2.2.1 Pharmaceutical Validation Services Market Size by Region: 2018 VS 2022 VS 2029
    • 2.2.2 Pharmaceutical Validation Services Historic Market Size by Region (2018-2023)
    • 2.2.3 Pharmaceutical Validation Services Forecasted Market Size by Region (2024-2029)
  • 2.3 Pharmaceutical Validation Services Market Dynamics
    • 2.3.1 Pharmaceutical Validation Services Industry Trends
    • 2.3.2 Pharmaceutical Validation Services Market Drivers
    • 2.3.3 Pharmaceutical Validation Services Market Challenges
    • 2.3.4 Pharmaceutical Validation Services Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Revenue Pharmaceutical Validation Services by Players
    • 3.1.1 Global Pharmaceutical Validation Services Revenue by Players (2018-2023)
    • 3.1.2 Global Pharmaceutical Validation Services Revenue Market Share by Players (2018-2023)
  • 3.2 Global Pharmaceutical Validation Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Global Key Players of Pharmaceutical Validation Services, Ranking by Revenue, 2021 VS 2022 VS 2023
  • 3.4 Global Pharmaceutical Validation Services Market Concentration Ratio
    • 3.4.1 Global Pharmaceutical Validation Services Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical Validation Services Revenue in 2022
  • 3.5 Global Key Players of Pharmaceutical Validation Services Head office and Area Served
  • 3.6 Global Key Players of Pharmaceutical Validation Services, Product and Application
  • 3.7 Global Key Players of Pharmaceutical Validation Services, Date of Enter into This Industry
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Pharmaceutical Validation Services Breakdown Data by Type

  • 4.1 Global Pharmaceutical Validation Services Historic Market Size by Type (2018-2023)
  • 4.2 Global Pharmaceutical Validation Services Forecasted Market Size by Type (2024-2029)

5 Pharmaceutical Validation Services Breakdown Data by Application

  • 5.1 Global Pharmaceutical Validation Services Historic Market Size by Application (2018-2023)
  • 5.2 Global Pharmaceutical Validation Services Forecasted Market Size by Application (2024-2029)

6 North America

  • 6.1 North America Pharmaceutical Validation Services Market Size (2018-2029)
  • 6.2 North America Pharmaceutical Validation Services Market Size by Type
    • 6.2.1 North America Pharmaceutical Validation Services Market Size by Type (2018-2023)
    • 6.2.2 North America Pharmaceutical Validation Services Market Size by Type (2024-2029)
    • 6.2.3 North America Pharmaceutical Validation Services Market Share by Type (2018-2029)
  • 6.3 North America Pharmaceutical Validation Services Market Size by Application
    • 6.3.1 North America Pharmaceutical Validation Services Market Size by Application (2018-2023)
    • 6.3.2 North America Pharmaceutical Validation Services Market Size by Application (2024-2029)
    • 6.3.3 North America Pharmaceutical Validation Services Market Share by Application (2018-2029)
  • 6.4 North America Pharmaceutical Validation Services Market Size by Country
    • 6.4.1 North America Pharmaceutical Validation Services Market Size by Country: 2018 VS 2022 VS 2029
    • 6.4.2 North America Pharmaceutical Validation Services Market Size by Country (2018-2023)
    • 6.4.3 North America Pharmaceutical Validation Services Market Size by Country (2024-2029)
    • 6.4.4 United States
    • 6.4.5 Canada

7 Europe

  • 7.1 Europe Pharmaceutical Validation Services Market Size (2018-2029)
  • 7.2 Europe Pharmaceutical Validation Services Market Size by Type
    • 7.2.1 Europe Pharmaceutical Validation Services Market Size by Type (2018-2023)
    • 7.2.2 Europe Pharmaceutical Validation Services Market Size by Type (2024-2029)
    • 7.2.3 Europe Pharmaceutical Validation Services Market Share by Type (2018-2029)
  • 7.3 Europe Pharmaceutical Validation Services Market Size by Application
    • 7.3.1 Europe Pharmaceutical Validation Services Market Size by Application (2018-2023)
    • 7.3.2 Europe Pharmaceutical Validation Services Market Size by Application (2024-2029)
    • 7.3.3 Europe Pharmaceutical Validation Services Market Share by Application (2018-2029)
  • 7.4 Europe Pharmaceutical Validation Services Market Size by Country
    • 7.4.1 Europe Pharmaceutical Validation Services Market Size by Country: 2018 VS 2022 VS 2029
    • 7.4.2 Europe Pharmaceutical Validation Services Market Size by Country (2018-2023)
    • 7.4.3 Europe Pharmaceutical Validation Services Market Size by Country (2024-2029)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic Countries

8 China

  • 8.1 China Pharmaceutical Validation Services Market Size (2018-2029)
  • 8.2 China Pharmaceutical Validation Services Market Size by Type
    • 8.2.1 China Pharmaceutical Validation Services Market Size by Type (2018-2023)
    • 8.2.2 China Pharmaceutical Validation Services Market Size by Type (2024-2029)
    • 8.2.3 China Pharmaceutical Validation Services Market Share by Type (2018-2029)
  • 8.3 China Pharmaceutical Validation Services Market Size by Application
    • 8.3.1 China Pharmaceutical Validation Services Market Size by Application (2018-2023)
    • 8.3.2 China Pharmaceutical Validation Services Market Size by Application (2024-2029)
    • 8.3.3 China Pharmaceutical Validation Services Market Share by Application (2018-2029)

9 Asia (excluding China)

  • 9.1 Asia Pharmaceutical Validation Services Market Size (2018-2029)
  • 9.2 Asia Pharmaceutical Validation Services Market Size by Type
    • 9.2.1 Asia Pharmaceutical Validation Services Market Size by Type (2018-2023)
    • 9.2.2 Asia Pharmaceutical Validation Services Market Size by Type (2024-2029)
    • 9.2.3 Asia Pharmaceutical Validation Services Market Share by Type (2018-2029)
  • 9.3 Asia Pharmaceutical Validation Services Market Size by Application
    • 9.3.1 Asia Pharmaceutical Validation Services Market Size by Application (2018-2023)
    • 9.3.2 Asia Pharmaceutical Validation Services Market Size by Application (2024-2029)
    • 9.3.3 Asia Pharmaceutical Validation Services Market Share by Application (2018-2029)
  • 9.4 Asia Pharmaceutical Validation Services Market Size by Region
    • 9.4.1 Asia Pharmaceutical Validation Services Market Size by Region: 2018 VS 2022 VS 2029
    • 9.4.2 Asia Pharmaceutical Validation Services Market Size by Region (2018-2023)
    • 9.4.3 Asia Pharmaceutical Validation Services Market Size by Region (2024-2029)
    • 9.4.4 Japan
    • 9.4.5 South Korea
    • 9.4.6 China Taiwan
    • 9.4.7 Southeast Asia
    • 9.4.8 India
    • 9.4.9 Australia

10 Middle East, Africa, and Latin America

  • 10.1 Middle East, Africa, and Latin America Pharmaceutical Validation Services Market Size (2018-2029)
  • 10.2 Middle East, Africa, and Latin America Pharmaceutical Validation Services Market Size by Type
    • 10.2.1 Middle East, Africa, and Latin America Pharmaceutical Validation Services Market Size by Type (2018-2023)
    • 10.2.2 Middle East, Africa, and Latin America Pharmaceutical Validation Services Market Size by Type (2024-2029)
    • 10.2.3 Middle East, Africa, and Latin America Pharmaceutical Validation Services Market Share by Type (2018-2029)
  • 10.3 Middle East, Africa, and Latin America Pharmaceutical Validation Services Market Size by Application
    • 10.3.1 Middle East, Africa, and Latin America Pharmaceutical Validation Services Market Size by Application (2018-2023)
    • 10.3.2 Middle East, Africa, and Latin America Pharmaceutical Validation Services Market Size by Application (2024-2029)
    • 10.3.3 Middle East, Africa, and Latin America Pharmaceutical Validation Services Market Share by Application (2018-2029)
  • 10.4 Middle East, Africa, and Latin America Pharmaceutical Validation Services Market Size by Country
    • 10.4.1 Middle East, Africa, and Latin America Pharmaceutical Validation Services Market Size by Country: 2018 VS 2022 VS 2029
    • 10.4.2 Middle East, Africa, and Latin America Pharmaceutical Validation Services Market Size by Country (2018-2023)
    • 10.4.3 Middle East, Africa, and Latin America Pharmaceutical Validation Services Market Size by Country (2024-2029)
    • 10.4.4 Brazil
    • 10.4.5 Mexico
    • 10.4.6 Turkey
    • 10.4.7 Saudi Arabia
    • 10.4.8 Israel
    • 10.4.9 GCC Countries

11 Key Players Profiles

  • 11.1 Arbor Group
    • 11.1.1 Arbor Group Company Details
    • 11.1.2 Arbor Group Business Overview
    • 11.1.3 Arbor Group Pharmaceutical Validation Services Introduction
    • 11.1.4 Arbor Group Revenue in Pharmaceutical Validation Services Business (2018-2023)
    • 11.1.5 Arbor Group Recent Developments
  • 11.2 ATS Global
    • 11.2.1 ATS Global Company Details
    • 11.2.2 ATS Global Business Overview
    • 11.2.3 ATS Global Pharmaceutical Validation Services Introduction
    • 11.2.4 ATS Global Revenue in Pharmaceutical Validation Services Business (2018-2023)
    • 11.2.5 ATS Global Recent Developments
  • 11.3 Catalent
    • 11.3.1 Catalent Company Details
    • 11.3.2 Catalent Business Overview
    • 11.3.3 Catalent Pharmaceutical Validation Services Introduction
    • 11.3.4 Catalent Revenue in Pharmaceutical Validation Services Business (2018-2023)
    • 11.3.5 Catalent Recent Developments
  • 11.4 CRS Pharma Solutions
    • 11.4.1 CRS Pharma Solutions Company Details
    • 11.4.2 CRS Pharma Solutions Business Overview
    • 11.4.3 CRS Pharma Solutions Pharmaceutical Validation Services Introduction
    • 11.4.4 CRS Pharma Solutions Revenue in Pharmaceutical Validation Services Business (2018-2023)
    • 11.4.5 CRS Pharma Solutions Recent Developments
  • 11.5 Eurofins Scientific
    • 11.5.1 Eurofins Scientific Company Details
    • 11.5.2 Eurofins Scientific Business Overview
    • 11.5.3 Eurofins Scientific Pharmaceutical Validation Services Introduction
    • 11.5.4 Eurofins Scientific Revenue in Pharmaceutical Validation Services Business (2018-2023)
    • 11.5.5 Eurofins Scientific Recent Developments
  • 11.6 Korber Pharma
    • 11.6.1 Korber Pharma Company Details
    • 11.6.2 Korber Pharma Business Overview
    • 11.6.3 Korber Pharma Pharmaceutical Validation Services Introduction
    • 11.6.4 Korber Pharma Revenue in Pharmaceutical Validation Services Business (2018-2023)
    • 11.6.5 Korber Pharma Recent Developments
  • 11.7 Merck Millipore
    • 11.7.1 Merck Millipore Company Details
    • 11.7.2 Merck Millipore Business Overview
    • 11.7.3 Merck Millipore Pharmaceutical Validation Services Introduction
    • 11.7.4 Merck Millipore Revenue in Pharmaceutical Validation Services Business (2018-2023)
    • 11.7.5 Merck Millipore Recent Developments
  • 11.8 MTS (Meissner Technical Services)
    • 11.8.1 MTS (Meissner Technical Services) Company Details
    • 11.8.2 MTS (Meissner Technical Services) Business Overview
    • 11.8.3 MTS (Meissner Technical Services) Pharmaceutical Validation Services Introduction
    • 11.8.4 MTS (Meissner Technical Services) Revenue in Pharmaceutical Validation Services Business (2018-2023)
    • 11.8.5 MTS (Meissner Technical Services) Recent Developments
  • 11.9 Navitas pharma READY
    • 11.9.1 Navitas pharma READY Company Details
    • 11.9.2 Navitas pharma READY Business Overview
    • 11.9.3 Navitas pharma READY Pharmaceutical Validation Services Introduction
    • 11.9.4 Navitas pharma READY Revenue in Pharmaceutical Validation Services Business (2018-2023)
    • 11.9.5 Navitas pharma READY Recent Developments
  • 11.10 PharmOut
    • 11.10.1 PharmOut Company Details
    • 11.10.2 PharmOut Business Overview
    • 11.10.3 PharmOut Pharmaceutical Validation Services Introduction
    • 11.10.4 PharmOut Revenue in Pharmaceutical Validation Services Business (2018-2023)
    • 11.10.5 PharmOut Recent Developments
  • 11.11 SGS
    • 11.11.1 SGS Company Details
    • 11.11.2 SGS Business Overview
    • 11.11.3 SGS Pharmaceutical Validation Services Introduction
    • 11.11.4 SGS Revenue in Pharmaceutical Validation Services Business (2018-2023)
    • 11.11.5 SGS Recent Developments
  • 11.12 Sigma-Aldrich
    • 11.12.1 Sigma-Aldrich Company Details
    • 11.12.2 Sigma-Aldrich Business Overview
    • 11.12.3 Sigma-Aldrich Pharmaceutical Validation Services Introduction
    • 11.12.4 Sigma-Aldrich Revenue in Pharmaceutical Validation Services Business (2018-2023)
    • 11.12.5 Sigma-Aldrich Recent Developments
  • 11.13 SL Controls
    • 11.13.1 SL Controls Company Details
    • 11.13.2 SL Controls Business Overview
    • 11.13.3 SL Controls Pharmaceutical Validation Services Introduction
    • 11.13.4 SL Controls Revenue in Pharmaceutical Validation Services Business (2018-2023)
    • 11.13.5 SL Controls Recent Developments
  • 11.14 Transcat
    • 11.14.1 Transcat Company Details
    • 11.14.2 Transcat Business Overview
    • 11.14.3 Transcat Pharmaceutical Validation Services Introduction
    • 11.14.4 Transcat Revenue in Pharmaceutical Validation Services Business (2018-2023)
    • 11.14.5 Transcat Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
  • 13.2 Disclaimer
  • 13.3 Author Details

TABLE OF CONTENTS

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Pharmaceutical Validation Services Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
    • 1.2.2 Pharmaceutical Cleaning Validation Services
    • 1.2.3 Pharmaceutical Equipment Validation Services
    • 1.2.4 Others
  • 1.3 Market by Application
    • 1.3.1 Global Pharmaceutical Validation Services Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
    • 1.3.2 Pharmaceutical Companies
    • 1.3.3 Biotechnological Companies
    • 1.3.4 Academic and Research Institutes
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Global Growth Trends

  • 2.1 Global Pharmaceutical Validation Services Market Perspective (2018-2029)
  • 2.2 Global Pharmaceutical Validation Services Growth Trends by Region
    • 2.2.1 Pharmaceutical Validation Services Market Size by Region: 2018 VS 2022 VS 2029
    • 2.2.2 Pharmaceutical Validation Services Historic Market Size by Region (2018-2023)
    • 2.2.3 Pharmaceutical Validation Services Forecasted Market Size by Region (2024-2029)
  • 2.3 Pharmaceutical Validation Services Market Dynamics
    • 2.3.1 Pharmaceutical Validation Services Industry Trends
    • 2.3.2 Pharmaceutical Validation Services Market Drivers
    • 2.3.3 Pharmaceutical Validation Services Market Challenges
    • 2.3.4 Pharmaceutical Validation Services Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Revenue Pharmaceutical Validation Services by Players
    • 3.1.1 Global Pharmaceutical Validation Services Revenue by Players (2018-2023)
    • 3.1.2 Global Pharmaceutical Validation Services Revenue Market Share by Players (2018-2023)
  • 3.2 Global Pharmaceutical Validation Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Global Key Players of Pharmaceutical Validation Services, Ranking by Revenue, 2021 VS 2022 VS 2023
  • 3.4 Global Pharmaceutical Validation Services Market Concentration Ratio
    • 3.4.1 Global Pharmaceutical Validation Services Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical Validation Services Revenue in 2022
  • 3.5 Global Key Players of Pharmaceutical Validation Services Head office and Area Served
  • 3.6 Global Key Players of Pharmaceutical Validation Services, Product and Application
  • 3.7 Global Key Players of Pharmaceutical Validation Services, Date of Enter into This Industry
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Pharmaceutical Validation Services Breakdown Data by Type

  • 4.1 Global Pharmaceutical Validation Services Historic Market Size by Type (2018-2023)
  • 4.2 Global Pharmaceutical Validation Services Forecasted Market Size by Type (2024-2029)

5 Pharmaceutical Validation Services Breakdown Data by Application

  • 5.1 Global Pharmaceutical Validation Services Historic Market Size by Application (2018-2023)
  • 5.2 Global Pharmaceutical Validation Services Forecasted Market Size by Application (2024-2029)

6 North America

  • 6.1 North America Pharmaceutical Validation Services Market Size (2018-2029)
  • 6.2 North America Pharmaceutical Validation Services Market Size by Type
    • 6.2.1 North America Pharmaceutical Validation Services Market Size by Type (2018-2023)
    • 6.2.2 North America Pharmaceutical Validation Services Market Size by Type (2024-2029)
    • 6.2.3 North America Pharmaceutical Validation Services Market Share by Type (2018-2029)
  • 6.3 North America Pharmaceutical Validation Services Market Size by Application
    • 6.3.1 North America Pharmaceutical Validation Services Market Size by Application (2018-2023)
    • 6.3.2 North America Pharmaceutical Validation Services Market Size by Application (2024-2029)
    • 6.3.3 North America Pharmaceutical Validation Services Market Share by Application (2018-2029)
  • 6.4 North America Pharmaceutical Validation Services Market Size by Country
    • 6.4.1 North America Pharmaceutical Validation Services Market Size by Country: 2018 VS 2022 VS 2029
    • 6.4.2 North America Pharmaceutical Validation Services Market Size by Country (2018-2023)
    • 6.4.3 North America Pharmaceutical Validation Services Market Size by Country (2024-2029)
    • 6.4.4 United States
    • 6.4.5 Canada

7 Europe

  • 7.1 Europe Pharmaceutical Validation Services Market Size (2018-2029)
  • 7.2 Europe Pharmaceutical Validation Services Market Size by Type
    • 7.2.1 Europe Pharmaceutical Validation Services Market Size by Type (2018-2023)
    • 7.2.2 Europe Pharmaceutical Validation Services Market Size by Type (2024-2029)
    • 7.2.3 Europe Pharmaceutical Validation Services Market Share by Type (2018-2029)
  • 7.3 Europe Pharmaceutical Validation Services Market Size by Application
    • 7.3.1 Europe Pharmaceutical Validation Services Market Size by Application (2018-2023)
    • 7.3.2 Europe Pharmaceutical Validation Services Market Size by Application (2024-2029)
    • 7.3.3 Europe Pharmaceutical Validation Services Market Share by Application (2018-2029)
  • 7.4 Europe Pharmaceutical Validation Services Market Size by Country
    • 7.4.1 Europe Pharmaceutical Validation Services Market Size by Country: 2018 VS 2022 VS 2029
    • 7.4.2 Europe Pharmaceutical Validation Services Market Size by Country (2018-2023)
    • 7.4.3 Europe Pharmaceutical Validation Services Market Size by Country (2024-2029)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic Countries

8 China

  • 8.1 China Pharmaceutical Validation Services Market Size (2018-2029)
  • 8.2 China Pharmaceutical Validation Services Market Size by Type
    • 8.2.1 China Pharmaceutical Validation Services Market Size by Type (2018-2023)
    • 8.2.2 China Pharmaceutical Validation Services Market Size by Type (2024-2029)
    • 8.2.3 China Pharmaceutical Validation Services Market Share by Type (2018-2029)
  • 8.3 China Pharmaceutical Validation Services Market Size by Application
    • 8.3.1 China Pharmaceutical Validation Services Market Size by Application (2018-2023)
    • 8.3.2 China Pharmaceutical Validation Services Market Size by Application (2024-2029)
    • 8.3.3 China Pharmaceutical Validation Services Market Share by Application (2018-2029)

9 Asia (excluding China)

  • 9.1 Asia Pharmaceutical Validation Services Market Size (2018-2029)
  • 9.2 Asia Pharmaceutical Validation Services Market Size by Type
    • 9.2.1 Asia Pharmaceutical Validation Services Market Size by Type (2018-2023)
    • 9.2.2 Asia Pharmaceutical Validation Services Market Size by Type (2024-2029)
    • 9.2.3 Asia Pharmaceutical Validation Services Market Share by Type (2018-2029)
  • 9.3 Asia Pharmaceutical Validation Services Market Size by Application
    • 9.3.1 Asia Pharmaceutical Validation Services Market Size by Application (2018-2023)
    • 9.3.2 Asia Pharmaceutical Validation Services Market Size by Application (2024-2029)
    • 9.3.3 Asia Pharmaceutical Validation Services Market Share by Application (2018-2029)
  • 9.4 Asia Pharmaceutical Validation Services Market Size by Region
    • 9.4.1 Asia Pharmaceutical Validation Services Market Size by Region: 2018 VS 2022 VS 2029
    • 9.4.2 Asia Pharmaceutical Validation Services Market Size by Region (2018-2023)
    • 9.4.3 Asia Pharmaceutical Validation Services Market Size by Region (2024-2029)
    • 9.4.4 Japan
    • 9.4.5 South Korea
    • 9.4.6 China Taiwan
    • 9.4.7 Southeast Asia
    • 9.4.8 India
    • 9.4.9 Australia

10 Middle East, Africa, and Latin America

  • 10.1 Middle East, Africa, and Latin America Pharmaceutical Validation Services Market Size (2018-2029)
  • 10.2 Middle East, Africa, and Latin America Pharmaceutical Validation Services Market Size by Type
    • 10.2.1 Middle East, Africa, and Latin America Pharmaceutical Validation Services Market Size by Type (2018-2023)
    • 10.2.2 Middle East, Africa, and Latin America Pharmaceutical Validation Services Market Size by Type (2024-2029)
    • 10.2.3 Middle East, Africa, and Latin America Pharmaceutical Validation Services Market Share by Type (2018-2029)
  • 10.3 Middle East, Africa, and Latin America Pharmaceutical Validation Services Market Size by Application
    • 10.3.1 Middle East, Africa, and Latin America Pharmaceutical Validation Services Market Size by Application (2018-2023)
    • 10.3.2 Middle East, Africa, and Latin America Pharmaceutical Validation Services Market Size by Application (2024-2029)
    • 10.3.3 Middle East, Africa, and Latin America Pharmaceutical Validation Services Market Share by Application (2018-2029)
  • 10.4 Middle East, Africa, and Latin America Pharmaceutical Validation Services Market Size by Country
    • 10.4.1 Middle East, Africa, and Latin America Pharmaceutical Validation Services Market Size by Country: 2018 VS 2022 VS 2029
    • 10.4.2 Middle East, Africa, and Latin America Pharmaceutical Validation Services Market Size by Country (2018-2023)
    • 10.4.3 Middle East, Africa, and Latin America Pharmaceutical Validation Services Market Size by Country (2024-2029)
    • 10.4.4 Brazil
    • 10.4.5 Mexico
    • 10.4.6 Turkey
    • 10.4.7 Saudi Arabia
    • 10.4.8 Israel
    • 10.4.9 GCC Countries

11 Key Players Profiles

  • 11.1 Arbor Group
    • 11.1.1 Arbor Group Company Details
    • 11.1.2 Arbor Group Business Overview
    • 11.1.3 Arbor Group Pharmaceutical Validation Services Introduction
    • 11.1.4 Arbor Group Revenue in Pharmaceutical Validation Services Business (2018-2023)
    • 11.1.5 Arbor Group Recent Developments
  • 11.2 ATS Global
    • 11.2.1 ATS Global Company Details
    • 11.2.2 ATS Global Business Overview
    • 11.2.3 ATS Global Pharmaceutical Validation Services Introduction
    • 11.2.4 ATS Global Revenue in Pharmaceutical Validation Services Business (2018-2023)
    • 11.2.5 ATS Global Recent Developments
  • 11.3 Catalent
    • 11.3.1 Catalent Company Details
    • 11.3.2 Catalent Business Overview
    • 11.3.3 Catalent Pharmaceutical Validation Services Introduction
    • 11.3.4 Catalent Revenue in Pharmaceutical Validation Services Business (2018-2023)
    • 11.3.5 Catalent Recent Developments
  • 11.4 CRS Pharma Solutions
    • 11.4.1 CRS Pharma Solutions Company Details
    • 11.4.2 CRS Pharma Solutions Business Overview
    • 11.4.3 CRS Pharma Solutions Pharmaceutical Validation Services Introduction
    • 11.4.4 CRS Pharma Solutions Revenue in Pharmaceutical Validation Services Business (2018-2023)
    • 11.4.5 CRS Pharma Solutions Recent Developments
  • 11.5 Eurofins Scientific
    • 11.5.1 Eurofins Scientific Company Details
    • 11.5.2 Eurofins Scientific Business Overview
    • 11.5.3 Eurofins Scientific Pharmaceutical Validation Services Introduction
    • 11.5.4 Eurofins Scientific Revenue in Pharmaceutical Validation Services Business (2018-2023)
    • 11.5.5 Eurofins Scientific Recent Developments
  • 11.6 Korber Pharma
    • 11.6.1 Korber Pharma Company Details
    • 11.6.2 Korber Pharma Business Overview
    • 11.6.3 Korber Pharma Pharmaceutical Validation Services Introduction
    • 11.6.4 Korber Pharma Revenue in Pharmaceutical Validation Services Business (2018-2023)
    • 11.6.5 Korber Pharma Recent Developments
  • 11.7 Merck Millipore
    • 11.7.1 Merck Millipore Company Details
    • 11.7.2 Merck Millipore Business Overview
    • 11.7.3 Merck Millipore Pharmaceutical Validation Services Introduction
    • 11.7.4 Merck Millipore Revenue in Pharmaceutical Validation Services Business (2018-2023)
    • 11.7.5 Merck Millipore Recent Developments
  • 11.8 MTS (Meissner Technical Services)
    • 11.8.1 MTS (Meissner Technical Services) Company Details
    • 11.8.2 MTS (Meissner Technical Services) Business Overview
    • 11.8.3 MTS (Meissner Technical Services) Pharmaceutical Validation Services Introduction
    • 11.8.4 MTS (Meissner Technical Services) Revenue in Pharmaceutical Validation Services Business (2018-2023)
    • 11.8.5 MTS (Meissner Technical Services) Recent Developments
  • 11.9 Navitas pharma READY
    • 11.9.1 Navitas pharma READY Company Details
    • 11.9.2 Navitas pharma READY Business Overview
    • 11.9.3 Navitas pharma READY Pharmaceutical Validation Services Introduction
    • 11.9.4 Navitas pharma READY Revenue in Pharmaceutical Validation Services Business (2018-2023)
    • 11.9.5 Navitas pharma READY Recent Developments
  • 11.10 PharmOut
    • 11.10.1 PharmOut Company Details
    • 11.10.2 PharmOut Business Overview
    • 11.10.3 PharmOut Pharmaceutical Validation Services Introduction
    • 11.10.4 PharmOut Revenue in Pharmaceutical Validation Services Business (2018-2023)
    • 11.10.5 PharmOut Recent Developments
  • 11.11 SGS
    • 11.11.1 SGS Company Details
    • 11.11.2 SGS Business Overview
    • 11.11.3 SGS Pharmaceutical Validation Services Introduction
    • 11.11.4 SGS Revenue in Pharmaceutical Validation Services Business (2018-2023)
    • 11.11.5 SGS Recent Developments
  • 11.12 Sigma-Aldrich
    • 11.12.1 Sigma-Aldrich Company Details
    • 11.12.2 Sigma-Aldrich Business Overview
    • 11.12.3 Sigma-Aldrich Pharmaceutical Validation Services Introduction
    • 11.12.4 Sigma-Aldrich Revenue in Pharmaceutical Validation Services Business (2018-2023)
    • 11.12.5 Sigma-Aldrich Recent Developments
  • 11.13 SL Controls
    • 11.13.1 SL Controls Company Details
    • 11.13.2 SL Controls Business Overview
    • 11.13.3 SL Controls Pharmaceutical Validation Services Introduction
    • 11.13.4 SL Controls Revenue in Pharmaceutical Validation Services Business (2018-2023)
    • 11.13.5 SL Controls Recent Developments
  • 11.14 Transcat
    • 11.14.1 Transcat Company Details
    • 11.14.2 Transcat Business Overview
    • 11.14.3 Transcat Pharmaceutical Validation Services Introduction
    • 11.14.4 Transcat Revenue in Pharmaceutical Validation Services Business (2018-2023)
    • 11.14.5 Transcat Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
  • 13.2 Disclaimer
  • 13.3 Author Details

List of Tables

  • Table 1. Global Pharmaceutical Validation Services Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
  • Table 2. Key Players of Pharmaceutical Cleaning Validation Services
  • Table 3. Key Players of Pharmaceutical Equipment Validation Services
  • Table 4. Key Players of Others
  • Table 5. Global Pharmaceutical Validation Services Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
  • Table 6. Global Pharmaceutical Validation Services Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
  • Table 7. Global Pharmaceutical Validation Services Market Size by Region (2018-2023) & (US$ Million)
  • Table 8. Global Pharmaceutical Validation Services Market Share by Region (2018-2023)
  • Table 9. Global Pharmaceutical Validation Services Forecasted Market Size by Region (2024-2029) & (US$ Million)
  • Table 10. Global Pharmaceutical Validation Services Market Share by Region (2024-2029)
  • Table 11. Pharmaceutical Validation Services Market Trends
  • Table 12. Pharmaceutical Validation Services Market Drivers
  • Table 13. Pharmaceutical Validation Services Market Challenges
  • Table 14. Pharmaceutical Validation Services Market Restraints
  • Table 15. Global Pharmaceutical Validation Services Revenue by Players (2018-2023) & (US$ Million)
  • Table 16. Global Pharmaceutical Validation Services Revenue Share by Players (2018-2023)
  • Table 17. Global Top Pharmaceutical Validation Services by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Validation Services as of 2022)
  • Table 18. Global Pharmaceutical Validation Services Industry Ranking 2021 VS 2022 VS 2023
  • Table 19. Global 5 Largest Players Market Share by Pharmaceutical Validation Services Revenue (CR5 and HHI) & (2018-2023)
  • Table 20. Global Key Players of Pharmaceutical Validation Services, Headquarters and Area Served
  • Table 21. Global Key Players of Pharmaceutical Validation Services, Product and Application
  • Table 22. Global Key Players of Pharmaceutical Validation Services, Product and Application
  • Table 23. Mergers & Acquisitions, Expansion Plans
  • Table 24. Global Pharmaceutical Validation Services Market Size by Type (2018-2023) & (US$ Million)
  • Table 25. Global Pharmaceutical Validation Services Revenue Market Share by Type (2018-2023)
  • Table 26. Global Pharmaceutical Validation Services Forecasted Market Size by Type (2024-2029) & (US$ Million)
  • Table 27. Global Pharmaceutical Validation Services Revenue Market Share by Type (2024-2029)
  • Table 28. Global Pharmaceutical Validation Services Market Size by Application (2018-2023) & (US$ Million)
  • Table 29. Global Pharmaceutical Validation Services Revenue Share by Application (2018-2023)
  • Table 30. Global Pharmaceutical Validation Services Forecasted Market Size by Application (2024-2029) & (US$ Million)
  • Table 31. Global Pharmaceutical Validation Services Revenue Share by Application (2024-2029)
  • Table 32. North America Pharmaceutical Validation Services Market Size by Type (2018-2023) & (US$ Million)
  • Table 33. North America Pharmaceutical Validation Services Market Size by Type (2024-2029) & (US$ Million)
  • Table 34. North America Pharmaceutical Validation Services Market Size by Application (2018-2023) & (US$ Million)
  • Table 35. North America Pharmaceutical Validation Services Market Size by Application (2024-2029) & (US$ Million)
  • Table 36. North America Pharmaceutical Validation Services Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
  • Table 37. North America Pharmaceutical Validation Services Market Size by Country (2018-2023) & (US$ Million)
  • Table 38. North America Pharmaceutical Validation Services Market Size by Country (2024-2029) & (US$ Million)
  • Table 39. Europe Pharmaceutical Validation Services Market Size by Type (2018-2023) & (US$ Million)
  • Table 40. Europe Pharmaceutical Validation Services Market Size by Type (2024-2029) & (US$ Million)
  • Table 41. Europe Pharmaceutical Validation Services Market Size by Application (2018-2023) & (US$ Million)
  • Table 42. Europe Pharmaceutical Validation Services Market Size by Application (2024-2029) & (US$ Million)
  • Table 43. Europe Pharmaceutical Validation Services Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
  • Table 44. Europe Pharmaceutical Validation Services Market Size by Country (2018-2023) & (US$ Million)
  • Table 45. Europe Pharmaceutical Validation Services Market Size by Country (2024-2029) & (US$ Million)
  • Table 46. China Pharmaceutical Validation Services Market Size by Type (2018-2023) & (US$ Million)
  • Table 47. China Pharmaceutical Validation Services Market Size by Type (2024-2029) & (US$ Million)
  • Table 48. China Pharmaceutical Validation Services Market Size by Application (2018-2023) & (US$ Million)
  • Table 49. China Pharmaceutical Validation Services Market Size by Application (2024-2029) & (US$ Million)
  • Table 50. Asia Pharmaceutical Validation Services Market Size by Type (2018-2023) & (US$ Million)
  • Table 51. Asia Pharmaceutical Validation Services Market Size by Type (2024-2029) & (US$ Million)
  • Table 52. Asia Pharmaceutical Validation Services Market Size by Application (2018-2023) & (US$ Million)
  • Table 53. Asia Pharmaceutical Validation Services Market Size by Application (2024-2029) & (US$ Million)
  • Table 54. Asia Pharmaceutical Validation Services Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
  • Table 55. Asia Pharmaceutical Validation Services Market Size by Region (2018-2023) & (US$ Million)
  • Table 56. Asia Pharmaceutical Validation Services Market Size by Region (2024-2029) & (US$ Million)
  • Table 57. Middle East, Africa, and Latin America Pharmaceutical Validation Services Market Size by Type (2018-2023) & (US$ Million)
  • Table 58. Middle East, Africa, and Latin America Pharmaceutical Validation Services Market Size by Type (2024-2029) & (US$ Million)
  • Table 59. Middle East, Africa, and Latin America Pharmaceutical Validation Services Market Size by Application (2018-2023) & (US$ Million)
  • Table 60. Middle East, Africa, and Latin America Pharmaceutical Validation Services Market Size by Application (2024-2029) & (US$ Million)
  • Table 61. Middle East, Africa, and Latin America Pharmaceutical Validation Services Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
  • Table 62. Middle East, Africa, and Latin America Pharmaceutical Validation Services Market Size by Country (2018-2023) & (US$ Million)
  • Table 63. Middle East, Africa, and Latin America Pharmaceutical Validation Services Market Size by Country (2024-2029) & (US$ Million)
  • Table 64. Arbor Group Company Details
  • Table 65. Arbor Group Business Overview
  • Table 66. Arbor Group Pharmaceutical Validation Services Product
  • Table 67. Arbor Group Revenue in Pharmaceutical Validation Services Business (2018-2023) & (US$ Million)
  • Table 68. Arbor Group Recent Developments
  • Table 69. ATS Global Company Details
  • Table 70. ATS Global Business Overview
  • Table 71. ATS Global Pharmaceutical Validation Services Product
  • Table 72. ATS Global Revenue in Pharmaceutical Validation Services Business (2018-2023) & (US$ Million)
  • Table 73. ATS Global Recent Developments
  • Table 74. Catalent Company Details
  • Table 75. Catalent Business Overview
  • Table 76. Catalent Pharmaceutical Validation Services Product
  • Table 77. Catalent Revenue in Pharmaceutical Validation Services Business (2018-2023) & (US$ Million)
  • Table 78. Catalent Recent Developments
  • Table 79. CRS Pharma Solutions Company Details
  • Table 80. CRS Pharma Solutions Business Overview
  • Table 81. CRS Pharma Solutions Pharmaceutical Validation Services Product
  • Table 82. CRS Pharma Solutions Revenue in Pharmaceutical Validation Services Business (2018-2023) & (US$ Million)
  • Table 83. CRS Pharma Solutions Recent Developments
  • Table 84. Eurofins Scientific Company Details
  • Table 85. Eurofins Scientific Business Overview
  • Table 86. Eurofins Scientific Pharmaceutical Validation Services Product
  • Table 87. Eurofins Scientific Revenue in Pharmaceutical Validation Services Business (2018-2023) & (US$ Million)
  • Table 88. Eurofins Scientific Recent Developments
  • Table 89. Korber Pharma Company Details
  • Table 90. Korber Pharma Business Overview
  • Table 91. Korber Pharma Pharmaceutical Validation Services Product
  • Table 92. Korber Pharma Revenue in Pharmaceutical Validation Services Business (2018-2023) & (US$ Million)
  • Table 93. Korber Pharma Recent Developments
  • Table 94. Merck Millipore Company Details
  • Table 95. Merck Millipore Business Overview
  • Table 96. Merck Millipore Pharmaceutical Validation Services Product
  • Table 97. Merck Millipore Revenue in Pharmaceutical Validation Services Business (2018-2023) & (US$ Million)
  • Table 98. Merck Millipore Recent Developments
  • Table 99. MTS (Meissner Technical Services) Company Details
  • Table 100. MTS (Meissner Technical Services) Business Overview
  • Table 101. MTS (Meissner Technical Services) Pharmaceutical Validation Services Product
  • Table 102. MTS (Meissner Technical Services) Revenue in Pharmaceutical Validation Services Business (2018-2023) & (US$ Million)
  • Table 103. MTS (Meissner Technical Services) Recent Developments
  • Table 104. Navitas pharma READY Company Details
  • Table 105. Navitas pharma READY Business Overview
  • Table 106. Navitas pharma READY Pharmaceutical Validation Services Product
  • Table 107. Navitas pharma READY Revenue in Pharmaceutical Validation Services Business (2018-2023) & (US$ Million)
  • Table 108. Navitas pharma READY Recent Developments
  • Table 109. PharmOut Company Details
  • Table 110. PharmOut Business Overview
  • Table 111. PharmOut Pharmaceutical Validation Services Product
  • Table 112. PharmOut Revenue in Pharmaceutical Validation Services Business (2018-2023) & (US$ Million)
  • Table 113. PharmOut Recent Developments
  • Table 114. SGS Company Details
  • Table 115. SGS Business Overview
  • Table 116. SGS Pharmaceutical Validation Services Product
  • Table 117. SGS Revenue in Pharmaceutical Validation Services Business (2018-2023) & (US$ Million)
  • Table 118. SGS Recent Developments
  • Table 119. Sigma-Aldrich Company Details
  • Table 120. Sigma-Aldrich Business Overview
  • Table 121. Sigma-Aldrich Pharmaceutical Validation Services Product
  • Table 122. Sigma-Aldrich Revenue in Pharmaceutical Validation Services Business (2018-2023) & (US$ Million)
  • Table 123. Sigma-Aldrich Recent Developments
  • Table 124. SL Controls Company Details
  • Table 125. SL Controls Business Overview
  • Table 126. SL Controls Pharmaceutical Validation Services Product
  • Table 127. SL Controls Revenue in Pharmaceutical Validation Services Business (2018-2023) & (US$ Million)
  • Table 128. SL Controls Recent Developments
  • Table 129. Transcat Company Details
  • Table 130. Transcat Business Overview
  • Table 131. Transcat Pharmaceutical Validation Services Product
  • Table 132. Transcat Revenue in Pharmaceutical Validation Services Business (2018-2023) & (US$ Million)
  • Table 133. Transcat Recent Developments
  • Table 134. Research Programs/Design for This Report
  • Table 135. Key Data Information from Secondary Sources
  • Table 136. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Global Pharmaceutical Validation Services Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
  • Figure 2. Global Pharmaceutical Validation Services Market Share by Type: 2022 VS 2029
  • Figure 3. Pharmaceutical Cleaning Validation Services Features
  • Figure 4. Pharmaceutical Equipment Validation Services Features
  • Figure 5. Others Features
  • Figure 6. Global Pharmaceutical Validation Services Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
  • Figure 7. Global Pharmaceutical Validation Services Market Share by Application: 2022 VS 2029
  • Figure 8. Pharmaceutical Companies Case Studies
  • Figure 9. Biotechnological Companies Case Studies
  • Figure 10. Academic and Research Institutes Case Studies
  • Figure 11. Pharmaceutical Validation Services Report Years Considered
  • Figure 12. Global Pharmaceutical Validation Services Market Size (US$ Million), Year-over-Year: 2018-2029
  • Figure 13. Global Pharmaceutical Validation Services Market Size, (US$ Million), 2018 VS 2022 VS 2029
  • Figure 14. Global Pharmaceutical Validation Services Market Share by Region: 2022 VS 2029
  • Figure 15. Global Pharmaceutical Validation Services Market Share by Players in 2022
  • Figure 16. Global Top Pharmaceutical Validation Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Validation Services as of 2022)
  • Figure 17. The Top 10 and 5 Players Market Share by Pharmaceutical Validation Services Revenue in 2022
  • Figure 18. North America Pharmaceutical Validation Services Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 19. North America Pharmaceutical Validation Services Market Share by Type (2018-2029)
  • Figure 20. North America Pharmaceutical Validation Services Market Share by Application (2018-2029)
  • Figure 21. North America Pharmaceutical Validation Services Market Share by Country (2018-2029)
  • Figure 22. United States Pharmaceutical Validation Services Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 23. Canada Pharmaceutical Validation Services Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 24. Europe Pharmaceutical Validation Services Market Size YoY (2018-2029) & (US$ Million)
  • Figure 25. Europe Pharmaceutical Validation Services Market Share by Type (2018-2029)
  • Figure 26. Europe Pharmaceutical Validation Services Market Share by Application (2018-2029)
  • Figure 27. Europe Pharmaceutical Validation Services Market Share by Country (2018-2029)
  • Figure 28. Germany Pharmaceutical Validation Services Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 29. France Pharmaceutical Validation Services Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 30. U.K. Pharmaceutical Validation Services Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 31. Italy Pharmaceutical Validation Services Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 32. Russia Pharmaceutical Validation Services Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 33. Nordic Countries Pharmaceutical Validation Services Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 34. China Pharmaceutical Validation Services Market Size YoY (2018-2029) & (US$ Million)
  • Figure 35. China Pharmaceutical Validation Services Market Share by Type (2018-2029)
  • Figure 36. China Pharmaceutical Validation Services Market Share by Application (2018-2029)
  • Figure 37. Asia Pharmaceutical Validation Services Market Size YoY (2018-2029) & (US$ Million)
  • Figure 38. Asia Pharmaceutical Validation Services Market Share by Type (2018-2029)
  • Figure 39. Asia Pharmaceutical Validation Services Market Share by Application (2018-2029)
  • Figure 40. Asia Pharmaceutical Validation Services Market Share by Region (2018-2029)
  • Figure 41. Japan Pharmaceutical Validation Services Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 42. South Korea Pharmaceutical Validation Services Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 43. China Taiwan Pharmaceutical Validation Services Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 44. Southeast Asia Pharmaceutical Validation Services Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 45. India Pharmaceutical Validation Services Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 46. Australia Pharmaceutical Validation Services Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 47. Middle East, Africa, and Latin America Pharmaceutical Validation Services Market Size YoY (2018-2029) & (US$ Million)
  • Figure 48. Middle East, Africa, and Latin America Pharmaceutical Validation Services Market Share by Type (2018-2029)
  • Figure 49. Middle East, Africa, and Latin America Pharmaceutical Validation Services Market Share by Application (2018-2029)
  • Figure 50. Middle East, Africa, and Latin America Pharmaceutical Validation Services Market Share by Country (2018-2029)
  • Figure 51. Brazil Pharmaceutical Validation Services Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 52. Mexico Pharmaceutical Validation Services Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 53. Turkey Pharmaceutical Validation Services Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 54. Saudi Arabia Pharmaceutical Validation Services Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 55. Israel Pharmaceutical Validation Services Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 56. GCC Countries Pharmaceutical Validation Services Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 57. Arbor Group Revenue Growth Rate in Pharmaceutical Validation Services Business (2018-2023)
  • Figure 58. ATS Global Revenue Growth Rate in Pharmaceutical Validation Services Business (2018-2023)
  • Figure 59. Catalent Revenue Growth Rate in Pharmaceutical Validation Services Business (2018-2023)
  • Figure 60. CRS Pharma Solutions Revenue Growth Rate in Pharmaceutical Validation Services Business (2018-2023)
  • Figure 61. Eurofins Scientific Revenue Growth Rate in Pharmaceutical Validation Services Business (2018-2023)
  • Figure 62. Korber Pharma Revenue Growth Rate in Pharmaceutical Validation Services Business (2018-2023)
  • Figure 63. Merck Millipore Revenue Growth Rate in Pharmaceutical Validation Services Business (2018-2023)
  • Figure 64. MTS (Meissner Technical Services) Revenue Growth Rate in Pharmaceutical Validation Services Business (2018-2023)
  • Figure 65. Navitas pharma READY Revenue Growth Rate in Pharmaceutical Validation Services Business (2018-2023)
  • Figure 66. PharmOut Revenue Growth Rate in Pharmaceutical Validation Services Business (2018-2023)
  • Figure 67. SGS Revenue Growth Rate in Pharmaceutical Validation Services Business (2018-2023)
  • Figure 68. Sigma-Aldrich Revenue Growth Rate in Pharmaceutical Validation Services Business (2018-2023)
  • Figure 69. SL Controls Revenue Growth Rate in Pharmaceutical Validation Services Business (2018-2023)
  • Figure 70. Transcat Revenue Growth Rate in Pharmaceutical Validation Services Business (2018-2023)
  • Figure 71. Bottom-up and Top-down Approaches for This Report
  • Figure 72. Data Triangulation
  • Figure 73. Key Executives Interviewed
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!